Investigation and analysis of the current implementation of the"guidelines for skin testing of β-lactam antibacterial drugs(2021 edition)"by some medical institutions
AIM To investigate the implementation status of the"guidelines for skin testing of β-lactam antibacterial drugs(2021 edition)"in some medical institutions.METHODS A questionnaire via Questionnaire Star was used to assess the management of cephalosporin skin tests and the level of understanding among medical personnel of the"guidelines for skin testing of β-lactam antibacterial drugs(2021 Edition)"in 56 medical institutions.RESULTS A total of 407 valid questionnaires were collected achieving a response rate of 100％.Following the issuance of the guidelines,the proportion of medical institutions that ceased performing cephalosporin skin tests increased from 17.86％to 58.93％,while 32.14％of medical institutions had not discontinued skin tests for cephalosporin drugs.Medical personnel had a high level of discernment regarding allergic history(97.79％),and a high accuracy rate in recording positive skin test results(96.07％).Furthermore,the majority of medical institutions(96.43％)provided training for the management of severe allergic reactions.However,there was a relatively low understanding of indications for cephalosporin skin tests,the significance of skin tests,the implications of positive/negative predictive values,and the medication for rescuing anaphylactic shock.CONCLUSION The implementation status of the guidelines is suboptimal.There is a need to improve the level of understanding of the guidelines among medical personnel.
β-lactamscephalosporinsantimicrobial drugskin test
国家科技期刊平台
NSTL
万方数据
